Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.

Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the founding of its Scientific Advisory Board (SAB) with ...

Somerset is proving that world-class ovarian cancer care is not just for big cities, with local survival rates now among the ...

Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound ...

The healthcare sector’s weight within the S&P 500 is approaching a 25-year low. This decline in weight indicates a reduced ...

Samitivej International Children's Hospital expands in Bangkok, enhancing pediatric care with advanced treatments and smart ...

There are now more ways than ever before to help cancer patients in the Fraser Valley thanks to the introduction of two new ...

Famous British journalist was saved thanks to the early diagnosis and surgical removal of cholangiocarcinoma by the Greek ...

The International Monetary Fund (IMF) recently commended Egypt's efforts to rebuild market confidence and stabilize the economy, citing a recovery in economic activity and progress in restoring ...

An impressive 77% of those diagnosed are now surviving beyond 12 months, with only one NHS trust surpassing this achievement.